Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Fed Regist ; 83(230): 61320-3, 2018 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-30497126

RESUMO

With the issuance of this final order, the Acting Administrator of the Drug Enforcement Administration maintains the placement of the substances furanyl fentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylfuran- 2-carboxamide], 4- fluoroisobutyryl fentanyl or parafluoroisobutyryl fentanyl [N-(4- fluorophenyl)-N-(1-phenethylpiperidin- 4-yl)isobutyramide], acryl fentanyl or acryloylfentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylacrylamide], tetrahydrofuranyl fentanyl [N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran-2- carboxamide], and ocfentanil [N-(2- fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4-yl)acetamide], including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, furanyl fentanyl, 4- fluoroisobutyryl fentanyl, acryl fentanyl, tetrahydrofuranyl fentanyl, and ocfentanil.


Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/classificação , Furanos/classificação , Piperidinas/classificação , Fentanila/análogos & derivados , Humanos , Estados Unidos
2.
Fed Regist ; 83(22): 4580-5, 2018 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-29932604

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule seven fentanyl-related substances in schedule I. These seven substances are: N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl), N-(4-fluorophenyl)N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl fentanyl), N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl), N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl), and N-(2- fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil). This action is based on a finding by the Administrator that the placement of these seven synthetic opioids in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, valeryl fentanyl, para-fluorobutyryl fentanyl, para-methoxybutyryl fentanyl, para-chloroisobutyryl fentanyl, isobutyryl fentanyl, cyclopentyl fentanyl, and ocfentanil.


Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/classificação , Fentanila/efeitos adversos , Fentanila/análise , Humanos , Drogas Ilícitas/efeitos adversos , Drogas Ilícitas/classificação , Saúde Pública , Estados Unidos
3.
Fed Regist ; 83(25): 5188-92, 2018 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-29932611

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule fentanyl-related substances that are not currently listed in any schedule of the Controlled Substances Act (CSA) and their isomers, esters, ethers, salts and salts of isomers, esters, and ethers in schedule I. This action is based on a finding by the Administrator that the placement of these synthetic opioids in schedule I is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle fentanyl-related substances.


Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/classificação , Fentanila/efeitos adversos , Fentanila/análogos & derivados , Humanos , Drogas Ilícitas/efeitos adversos , Drogas Ilícitas/classificação , Saúde Pública , Estados Unidos
4.
Fed Regist ; 83(3): 469-72, 2018 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-29319947

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, -(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (cyclopropyl fentanyl), and its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers in schedule I. This action is based on a finding by the Administrator that the placement of cyclopropyl fentanyl in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, cyclopropyl fentanyl.


Assuntos
Analgésicos Opioides/análise , Analgésicos Opioides/classificação , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/análogos & derivados , Fentanila/classificação , Humanos , Drogas Ilícitas/efeitos adversos , Estados Unidos
5.
Fed Regist ; 83(77): 17486-8, 2018 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-30016012

RESUMO

With the issuance of this final order, the Administrator of the Drug Enforcement Administration maintains the placement of the substances butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) and U­47700 (3,4-dichloro-N-[2- (dimethylamino)cyclohexyl]-Nmethylbenzamide), including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, butyryl fentanyl and U­ 47700.


Assuntos
Benzamidas/classificação , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/classificação , Analgésicos Opioides , Benzamidas/efeitos adversos , Fentanila/efeitos adversos , Fentanila/análogos & derivados , Humanos , Drogas Ilícitas , Estados Unidos
6.
Fed Regist ; 82(84): 20544-8, 2017 05 03.
Artigo em Inglês | MEDLINE | ID: mdl-28497944

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters, and ethers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of 4-fluoroisobutyryl fentanyl into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, 4-fluoroisobutyryl fentanyl.


Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/classificação , Fentanila/efeitos adversos , Fentanila/análogos & derivados , Humanos , Drogas Ilícitas/classificação , Legislação de Medicamentos , Saúde Pública , Estados Unidos
7.
Fed Regist ; 82(108): 26349-51, 2017 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-28591974

RESUMO

With the issuance of this final order, the Administrator of the Drug Enforcement Administration will maintain the placement of the substance acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act and is required in order for the United States to discharge its obligations under the Single Convention on Narcotic Drugs, 1961. This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, acetyl fentanyl.


Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/análogos & derivados , Fentanila/classificação , Fentanila/efeitos adversos , Humanos , Drogas Ilícitas/efeitos adversos , Drogas Ilícitas/legislação & jurisprudência , Estados Unidos
8.
Fed Regist ; 82(134): 32453-7, 2017 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-28715161

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or acryloylfentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters, and ethers, into Schedule I. This action is based on a finding by the Administrator that the placement of acryl fentanyl into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, acryl fentanyl.


Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/classificação , Analgésicos Opioides/classificação , Fentanila/análise , Humanos , Drogas Ilícitas/classificação , Drogas Ilícitas/legislação & jurisprudência , Saúde Pública , Estados Unidos
9.
Fed Regist ; 82(206): 49504-8, 2017 Oct 26.
Artigo em Inglês | MEDLINE | ID: mdl-29091366

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic opioids, N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl or 2-fluorofentanyl), N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (tetrahydrofuranyl fentanyl), and 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl fentanyl), into Schedule I. This action is based on a finding by the Administrator that the placement of ortho-fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, ortho-fluorofentanyl, tetrahydrofuranyl fentanyl, and methoxyacetyl fentanyl.


Assuntos
Analgésicos Opioides/classificação , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/análise , Fentanila/classificação , Analgésicos Opioides/efeitos adversos , Fentanila/efeitos adversos , Humanos , Drogas Ilícitas/efeitos adversos , Drogas Ilícitas/classificação , Estados Unidos
10.
Fed Regist ; 81(166): 58834-40, 2016 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-27568479

RESUMO

The Drug Enforcement Administration is placing the substance thiafentanil (4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine), including its isomers, esters, ethers, salts and salts of isomers, esters and ethers as possible, into schedule II of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act, as revised by the Improving Regulatory Transparency for New Medical Therapies Act which was signed into law on November 25, 2015.


Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/análogos & derivados , Fentanila/classificação , Analgésicos Opioides/classificação , Humanos , Estados Unidos
11.
Fed Regist ; 81(229): 85873-7, 2016 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-27906535

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (furanyl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters and ethers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of furanyl fentanyl into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, furanyl fentanyl.


Assuntos
Analgésicos Opioides/classificação , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/análise , Fentanila/classificação , Humanos , Estados Unidos
12.
Fed Regist ; 80(137): 42381-5, 2015 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-26189217

RESUMO

The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl), and its optical, positional, and geometric isomers, salts and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of this opioid substance into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, or possess), or propose to handle, acetyl fentanyl.


Assuntos
Drogas Desenhadas/classificação , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Fentanila/análogos & derivados , Fentanila/classificação , Analgésicos Opioides/classificação , Humanos , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Saúde Pública , Estados Unidos
13.
Toxicol Lett ; 317: 53-58, 2019 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-31560942

RESUMO

In 2017, the U.S. Department of Health and Human Services and the White House declared a public health emergency to address the opioid crisis (Hargan, 2017). On average, 192 Americans died from drug overdoses each day in 2017; 130 (67%) of those died specifically because of opioids (Scholl et al., 2019). Since 2013, there have been significant increases in overdose deaths involving synthetic opioids - particularly those involving illicitly-manufactured fentanyl. The U.S. Drug Enforcement Administration (DEA) estimates that 75% of all opioid identifications are illicit fentanyls (DEA, 2018b). Laboratories are routinely asked to confirm which fentanyl or other opioids are involved in an overdose or encountered by first responders. It is critical to identify and classify the types of drugs involved in an overdose, how often they are involved, and how that involvement may change over time. Health care providers, public health professionals, and law enforcement officers need to know which opioids are in use to treat, monitor, and investigate fatal and non-fatal overdoses. By knowing which drugs are present, appropriate prevention and response activities can be implemented. Laboratory testing is available for clinically used and widely recognized opioids. However, there has been a rapid expansion in new illicit opioids, particularly fentanyl analogs that may not be addressed by current laboratory capabilities. In order to test for these new opioids, laboratories require reference standards for the large number of possible fentanyls. To address this need, the Centers for Disease Control and Prevention (CDC) developed the Traceable Opioid Material§ Kits product line, which provides over 150 opioid reference standards, including over 100 fentanyl analogs. These kits were designed to dramatically increase laboratory capability to confirm which opioids are on the streets and causing deaths. The kits are free to U.S based laboratories in the public, private, clinical, law enforcement, research, and public health domains.


Assuntos
Analgésicos Opioides/análise , Overdose de Drogas/diagnóstico , Fentanila/análise , Transtornos Relacionados ao Uso de Opioides/diagnóstico , Kit de Reagentes para Diagnóstico/normas , Detecção do Abuso de Substâncias/normas , Analgésicos Opioides/classificação , Calibragem , Overdose de Drogas/mortalidade , Fentanila/análogos & derivados , Fentanila/classificação , Humanos , Transtornos Relacionados ao Uso de Opioides/mortalidade , Valor Preditivo dos Testes , Padrões de Referência , Reprodutibilidade dos Testes , Estados Unidos/epidemiologia
15.
Rev. Fac. Cienc. Méd. (Quito) ; 19(1/4): 16-20, ene.-dic. 1994. ilus, graf
Artigo em Espanhol | LILACS | ID: lil-178159

RESUMO

En pacientes ASA I y II, se evalúa las ventajas que tiene la adición de un narcótico, en este caso el fentanil (100 ug), a la solución del anestésico local (lidoca{ina al 2 por ciento con epinefrina 1:200.000(13cc). La presión arterial sitólica desciende en un 10 por ciento del valor inicial a los 5 minutos retornando a los valores basales aproxidamente a los quince minutos, la frecuencia cardíaca sufre pocas variaciones, sin significación clínica ni estadística. El APGAR del recién nacido tiene una media de (8.5) al primer minuto, y de 9.8) a los cinco minutos. No se reportó complicaciones inherentes a la técnica anestésica durante el seguimiento que se realizó de los niñoa a las 12 y 24 horas...


Assuntos
Humanos , Anestesia Epidural , Anestesia Epidural/classificação , Cesárea/classificação , Cesárea/métodos , Fentanila/administração & dosagem , Fentanila/análise , Fentanila/classificação , Fentanila/uso terapêutico , Lidocaína/administração & dosagem , Lidocaína/análise , Lidocaína/classificação , Lidocaína/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA